537033-56-0 Usage
Uses
Used in Pharmaceutical Industry:
4-BROMO-2,3,6-TRIFLUOROBENZALDEHYDE is used as an intermediate in the synthesis of various compounds for its potential as a building block in the development of new drugs. Its unique structure and reactivity contribute to the production of biologically active molecules with diverse applications in medicine.
Used in Agrochemical Industry:
In the agrochemical industry, 4-BROMO-2,3,6-TRIFLUOROBENZALDEHYDE serves as an intermediate in the synthesis of various compounds, playing a crucial role in the development of new pesticides. Its chemical properties allow for the creation of effective and targeted pest control solutions.
Used in Materials Science:
4-BROMO-2,3,6-TRIFLUOROBENZALDEHYDE may also have applications in the field of materials science, where its unique structure could be utilized in the development of new materials with specific properties for various industrial applications.
Used in Other Industrial Applications:
Beyond the pharmaceutical and agrochemical industries, 4-BROMO-2,3,6-TRIFLUOROBENZALDEHYDE's potential uses extend to other areas of industry, where its chemical properties can be leveraged to create innovative products and solutions.
Check Digit Verification of cas no
The CAS Registry Mumber 537033-56-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,3,7,0,3 and 3 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 537033-56:
(8*5)+(7*3)+(6*7)+(5*0)+(4*3)+(3*3)+(2*5)+(1*6)=140
140 % 10 = 0
So 537033-56-0 is a valid CAS Registry Number.
537033-56-0Relevant academic research and scientific papers
P2X3 MODULATORS
-
Paragraph 00237, (2021/08/20)
Provided herein are P2X3 modulators and methods of utilizing P2X3 modulators in the treatment of diseases, disorders, or conditions. Also described herein are pharmaceutical compositions containing such compounds.
N-SUBSTITUTED-3,4-(FUSED 5-RING)-5-PHENYL-PYRROLIDINE-2-ONE COMPOUNDS AS INHIBITORS OF ISOQC AND/OR QC ENZYME
-
Page/Page column 354, (2021/02/12)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain N-substituted-3,4-(fused 5-ring)-5-phenyl-pyrrolidin-2-one compounds (also referred to herein as "FRPPO compounds"), that, inter alia, inhibit glutaminyl-peptide cyclotransferase-like (isoQC) enzyme and/or glutaminyl-peptide cyclotransferase (QC) enzyme (e.g., inhibit or reduce or block the activity or function of isoQC and/or QC enzyme). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, to inhibit isoQC and/or QC enzyme; to treat disorders that are ameliorated by the inhibition of isoQC and/or QC enzyme; to treat cancer, atherosclerosis, fibrotic diseases, infectious diseases, Alzheimer's disease, etc.
